Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

 

Gainers

  • Genocea Biosciences (NASDAQ:GNCA) shares moved upwards by 70.9% to $0.1 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.1 million.
  • Motus GI Hldgs (NASDAQ:MOTS) shares rose 32.85% to $0.34. The market value of their outstanding shares is at $18.8 million.
  • Cingulate (NASDAQ:CING) stock increased by 15.04% to $1.3. The market value of their outstanding shares is at $14.7 million.
  • AcelRx Pharmaceuticals (NASDAQ:ACRX) shares increased by 12.2% to $0.25. The company's market cap stands at $36.7 million.
  • Aprea Therapeutics (NASDAQ:APRE) shares moved upwards by 10.71% to $0.74. The company's market cap stands at $16.2 million.
  • Vallon Pharmaceuticals (NASDAQ:VLON) shares moved upwards by 10.55% to $0.57. The market value of their outstanding shares is at $5.9 million.

Losers

  • Verrica Pharmaceuticals (NASDAQ:VRCA) stock declined by 54.9% to $2.51 during Wednesday's pre-market session. The company's market cap stands at $69.0 million.
  • Roivant Sciences (NASDAQ:ROIV) stock decreased by 13.3% to $3.39. The market value of their outstanding shares is at $2.3 billion.
  • NexGel (NASDAQ:NXGL) stock fell 12.86% to $1.22. The market value of their outstanding shares is at $6.7 million.
  • Better Therapeutics (NASDAQ:BTTX) stock fell 12.33% to $1.92. The market value of their outstanding shares is at $45.3 million.
  • BIMI Intl Medical (NASDAQ:BIMI) shares declined by 10.98% to $0.56. The company's market cap stands at $5.7 million. As per the press release, Q1 earnings came out 3 days ago.
  • Soligenix (NASDAQ:SNGX) stock decreased by 10.49% to $0.51. The market value of their outstanding shares is at $21.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.